Similar Articles
Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations
Joy Artin, Yumn A. Elsabagh, Laila Rashed, Mohamed A. Hussein
DOI: 10.46497/ArchRheumatol.2023.9638
Real-life data on the comorbidities in spondyloarthritis from our multicenter nationwide registry: BioStar
H. Fatih Çay, Meltem Alkan Melikoğlu, Fatma Gül Yurdakul, Hatice Bodur, Şebnem Ataman, Erhan Çapkın, Gülcan Gürer, İlhan Sezer, M. Tuncay Duruöz, Aylin Rezvani, İlker Yağcı, Feride Göğüş, Ayhan Kamanli, Remzi Çevik, Özgür Akgül
DOI: 10.46497/ArchRheumatol.2023.9793
Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database
Emine Duygu Ersözlü, Mustafa Ekici, Belkis Nihan Coşkun, Suade Özlem Badak, Emre Bilgin, Umut Kalyoncu, Burcu Yağız, Yavuz Pehlivan, Orhan Küçükşahin, Abdulsamet Erden, Dilek Solmaz, Pamir Atagündüz, Gezmiş Kimyon, Cemal Beş, Seda Çolak, Rıdvan Mercan, Timuçin Kaşifoğlu, Hakan Emmungil, Nilüfer Alpay Kanıtez, Aşkın Ateş, Süleyman Serdar Koca, Sedat Kiraz, İhsan Ertenli
DOI: 10.46497/ArchRheumatol.2023.9504
Beyond the horizon: Innovations and future directions in axial-spondyloarthritis
Vincenzo Venerito, Sergio Del Vescovo, Giuseppe Lopalco, Fabian Proft
DOI: 10.46497/ArchRheumatol.2023.10580
Correlation between clinical disease activity and sacroiliac magnetic resonance imaging detection in axial spondyloarthropathy
Ozenc Inan, Ebru Aytekin, Yasemin Pekin Dogan, Ilhan Nahit Mutlu, Kübra Aydemir, Nuran Oz, Nil Sayiner Caglar
DOI: 10.46497/ArchRheumatol.2024.10401
Alarming serum antiprotease levels in axial spondyloarthritis
Ayhan Kul, Zeynep Tüzün, Muhammet Çelik
DOI: 10.46497/ArchRheumatol.2024.10466
Regional variations in psoriatic arthritis: Insights from a nationwide multicenter analysis in Türkiye
Erkan Kılıç, Gamze Kılıç, İbrahim Tekeoğlu, Betül Sargın, Sevtap Acer Kasman, Hakan Alkan, Nilay Şahin, Gizem Cengiz, Nihan Cüzdan, İlknur Albayrak Gezer, Dilek Keskin, Cevriye Mülkoğlu, Hatice Reşorlu, İsmihan Sunar, Ajda Bal, Mehmet Tuncay Duruöz, Okan Küçükakkaş, Ozan Volkan Yurdakul, Meltem Alkan Melikoğlu, Yıldıray Aydın, Fikriye Figen Ayhan, Hatice Bodur, Mustafa Çalış, Erhan Çapkın, Gül Devrimsel, Kevser Orhan, Sami Hizmetli, Ayhan Kamanlı, Yaşar Keskin, Hilal Ecesoy, Öznur Kutluk, Nesrin Şen, Ömer Faruk Şendur, Sena Tolu, Murat Toprak, Tiraje Tuncer, Kemal Nas
DOI: 10.46497/ArchRheumatol.2024.10591
Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?
Rezan Koçak Ulucaköy, Ayza Kılıç, Sevilay Batıbay, İdil Melis Çobanoğlu, Elif Nur Yıldırım Öztürk, Zafer Günendi, Aylin Sepici Dinçel, Feride Nur Göğüş
DOI: 10.46497/ArchRheumatol.2024.10360
Difficult-to-treat axial spondyloarthritis patients
Tahir Saygın Öğüt, Funda Erbasan, Mehmet Fatih Şahiner, Mine Nokay, Ayşe Yörük Öğüt, Melis Dilbil, Mustafa Ender Terzioğlu, Veli Yazısız
DOI: 10.46497/ArchRheumatol.2024.10567